We’re on a mission to shape the future of research-driven cannabis education.
Curaleaf Education’s course reflects that commitment through:
All materials are developed within a formal governance framework designed to ensure accuracy, balance, and professional integrity.
Robust clinical governance and clearly defined quality assurance processes underpin our medical cannabis course. These systems ensure that all content remains accurate and professionally rigorous.
The programme is overseen by the Curaleaf Education Panel, led by senior medical leadership. All content undergoes structured clinical review before publication and is reassessed at defined intervals to ensure continued relevance and compliance.
This includes:
We prioritise clarity and professional neutrality. All of our educational materials:
This approach reflects Curaleaf Education’s broader commitment to research and innovation.
Dr Simon Erridge is Research Director at Curaleaf Clinic, UK, and an academic clinician experienced in embedding evidence-based research into his practice. He has published over 100 peer-reviewed publications, including those from his PhD examining the effects of medical cannabis on chronic pain.
As Lead Author, Dr Erridge has shaped the educational framework and evidence synthesis underpinning the clinical content of the course.
Dr Mikael Sodergren is Chief Medical Officer at Curaleaf International and a Clinical Associate Professor of Surgery and Technological Innovation. In his roles, he has established a bench-to-bedside research programme to evaluate and develop novel medicines derived from cannabis.
As Head of the Educational Panel, he provides senior clinical input and oversight to support the scientific integrity and quality of the course.
This course has been created and reviewed with input from members of the multidisciplinary clinical team at Curaleaf Clinic in the UK.
Curaleaf Clinic was the first medical cannabis clinic in the UK to be approved and regulated by the Care Quality Commission (CQC). Clinical practice aligns with guidance from the General Medical Council (GMC), the Medicines and Healthcare products Regulatory Agency (MHRA), and NHS England. Care delivery is informed by ongoing appraisal of emerging research and evolving regulatory standards.
UK clinical contributors include specialists across a range of disciplines:
Clinical insight from this multidisciplinary team informs the practical elements of the course, ensuring that content reflects real-world UK prescribing standards, governance requirements, and patient safety considerations.
Dr Diana Kadetoff is a senior physician with extensive experience in multidisciplinary chronic pain management. She previously served as senior physician and unit manager at Capio Spine Center Stockholm and completed her doctoral research on fibromyalgia at Karolinska Institutet. Dr Kadetoff’s expertise informs the course’s approach to complex pain and long-term conditions.
Dr Lisa Palmlöf is a specialist in rehabilitation medicine with experience in highly specialised, team-based pain care at Danderyd Hospital Rehabilitation Medicine University Clinic. She’s also worked in neurological rehabilitation in different hospitals and has specialist education in Functional Medicine.
Dr Palmlöf contributes expertise in functional assessment and integrated rehabilitation models. She also has a Postgraduate Certificate (PGCert) in cognitive behavioural therapy (CBT).
A graduate of the Medical University of Lublin, Dr Paweł Dryżałowski specialises in paediatric neurology. Dr Dryżałowski has authored and contributed to numerous scientific publications and textbook chapters in neurology. He lectures at national and international conferences on neurology and pain management, and is an active educator in phytocannabinoid therapy. Dr Dryżałowski’s contribution strengthens the course’s neurological and educational perspectives.
Medical cannabis research and regulatory frameworks continue to evolve.
To ensure the programme remains current and clinically robust:
We aim to provide education that is trustworthy, innovative, and globally adaptable – supporting clinicians to make informed, responsible decisions in practice.